Premium
Treatments for non‐Hodgkin lymphoma in HIV‐positive patients: Quantifying incremental benefit from 1993 to 2004 by metaregression
Author(s) -
Messori Andrea,
Fadda Valeria,
Maratea Dario,
Trippoli Sabrina
Publication year - 2013
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.23420
Subject(s) - medicine , hazard ratio , rituximab , oncology , confidence interval , meta analysis , lymphoma , odds ratio , non hodgkin's lymphoma , prospective cohort study
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom